Carisma Therapeutics, Inc. Stock
Stocks
CARM
US14216R1014
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
15:19:26 2026-09-29 EDT
|
5-day change | 1st Jan Change | ||
| 0.000700 USD | 0.00% |
|
-36.36% | -98.37% |
| Market Cap | 1.8M 1.59M 1.5M 1.36M 2.55M 173M 2.58M 18.02M 6.95M 88.17M 6.76M 6.61M 284M | P/E 2023 |
-1.13x | P/E 2024 | -0.29x |
|---|---|---|---|---|---|
| Enterprise Value | -14.55M -12.84M -12.15M -11.02M -20.66M -1.4B -20.87M -146M -56.18M -713M -54.65M -53.46M -2.29B | EV / Sales 2023 |
2,933,403x | EV / Sales 2024 | 57,658x |
| Free-Float |
76.96% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 week | -36.36% | ||
| Current month | -46.15% | ||
| 1 month | -46.15% | ||
| 3 months | -88.14% | ||
| 6 months | -97.88% | ||
| Current year | -98.37% |
| 1 week | 0 |  | 0 |
| 1 month | 0 | | 0 |
| Current year | 0 | | 0.05 |
| 1 year | 0 | | 0.29 |
| 3 years | 0 | | 4.86 |
| 5 years | 0 | | 9.77 |
| 10 years | 0 | | 9.77 |
| Manager | Title | Age | Since |
|---|---|---|---|
Craig Jalbert
CEO | Chief Executive Officer | 65 | 2025-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Craig Jalbert
BRD | Director/Board Member | 65 | 2025-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/7/25 | Exercice | Founder | 170,946 | 0.4095% | ||
| 10/1/25 | Sell | Founder | 484,347 | 1.1601% | ||
| 1/28/25 | Free | Chief Executive Officer | 500,000 | 1.1976% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -36.36% | -99.76% | -99.98% | 29.29K | |
| -0.70% | -4.28% | +52.62% | +86.42% | 71.53B | |
| +0.35% | +1.87% | +37.95% | +82.31% | 60.12B | |
| +4.77% | +6.16% | +36.77% | +26.10% | 27.98B | |
| -1.73% | -4.30% | -18.37% | +357.94% | 25.25B | |
| -0.51% | -2.28% | +0.48% | -9.27% | 24.76B | |
| +0.88% | +2.01% | +21.30% | -4.34% | 20.99B | |
| +3.46% | +3.02% | +158.90% | +337.81% | 15.54B | |
| +0.48% | +0.86% | +44.56% | +168.42% | 14.53B | |
| +2.96% | +0.83% | -5.25% | +519.59% | 14.41B | |
| Average | +1.00% | -4.35% | +22.92% | +146.50% | 27.51B | |
| Weighted average by Cap. | +0.62% | -1.52% | +36.75% | +129.99% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 14.92 13.17 12.46 11.3 21.18 1.43K 21.39 149.44 57.59 731.03 56.02 54.8 2.35K | 19.63 17.33 16.39 14.87 27.87 1.88K 28.15 196.65 75.79 961.96 73.72 72.11 3.1K |
| Net income | -86.88M -76.67M -72.54M -65.79M -123M -8.34B -125M -870M -335M -4.26B -326M -319M -13.7B | -60.48M -53.37M -50.5M -45.8M -85.86M -5.8B -86.71M -606M -233M -2.96B -227M -222M -9.54B |
| Net Debt | -74.48M -65.73M -62.19M -56.4M -106M -7.15B -107M -746M -288M -3.65B -280M -274M -11.74B | -16.35M -14.43M -13.65M -12.38M -23.22M -1.57B -23.45M -164M -63.13M -801M -61.41M -60.07M -2.58B |
Employees
46
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-29 | US$0.000700 | 0.00% | 921 |
| 26-09-28 | US$0.000700 | -12.50% | 2,591 |
| 26-09-25 | US$0.000800 | +14.29% | 9,790 |
| 26-09-24 | US$0.000700 | 0.00% | 1,300 |
| 26-09-23 | US$0.000700 | -36.36% | 1,495 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CARM Stock
Select your edition
All financial news and data tailored to specific country editions
